| A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy KB Johnsen, JM Gudbergsson, MN Skov, L Pilgaard, T Moos, M Duroux Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 75-87, 2014 | 773 | 2014 |
| A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion HG Møller, AP Rasmussen, HH Andersen, KB Johnsen, M Henriksen, ... Molecular neurobiology 47, 131-144, 2013 | 327 | 2013 |
| Targeting the transferrin receptor for brain drug delivery KB Johnsen, A Burkhart, LB Thomsen, TL Andresen, T Moos Progress in neurobiology 181, 101665, 2019 | 282 | 2019 |
| Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma KB Johnsen, A Burkhart, F Melander, PJ Kempen, JB Vejlebo, P Siupka, ... Scientific reports 7 (1), 1-13, 2017 | 258 | 2017 |
| What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer KB Johnsen, JM Gudbergsson, TL Andresen, JB Simonsen Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (1), 109-116, 2019 | 248 | 2019 |
| Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes KB Johnsen, JM Gudbergsson, MN Skov, G Christiansen, L Gurevich, ... Cytotechnology 68, 2125-2138, 2016 | 204 | 2016 |
| Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration HH Andersen, KB Johnsen, T Moos Cellular and Molecular Life Sciences 71, 1607-1622, 2014 | 173 | 2014 |
| Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology T Skjørringe, A Burkhart, KB Johnsen, T Moos Frontiers in Molecular Neuroscience 8, 19, 2015 | 163 | 2015 |
| Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo KB Johnsen, M Bak, F Melander, MS Thomsen, A Burkhart, PJ Kempen, ... Journal of Controlled Release 295, 237-249, 2019 | 149 | 2019 |
| Systematic review of factors influencing extracellular vesicle yield from cell cultures JM Gudbergsson, KB Johnsen, MN Skov, M Duroux Cytotechnology 68, 579-592, 2016 | 142 | 2016 |
| Revisiting nanoparticle technology for blood–brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes KB Johnsen, T Moos Journal of Controlled Release 222, 32-46, 2016 | 142 | 2016 |
| Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles KB Johnsen, M Bak, PJ Kempen, F Melander, A Burkhart, MS Thomsen, ... Theranostics 8 (12), 3416, 2018 | 133 | 2018 |
| Systematic review of targeted extracellular vesicles for drug delivery–considerations on methodological and biological heterogeneity JM Gudbergsson, K Jønsson, JB Simonsen, KB Johnsen Journal of Controlled Release 306, 108-120, 2019 | 127 | 2019 |
| Expression of iron-related proteins at the neurovascular unit supports reduction and reoxidation of iron for transport through the blood-brain barrier A Burkhart, T Skjørringe, KB Johnsen, P Siupka, LB Thomsen, MS Nielsen, ... Molecular neurobiology 53, 7237-7253, 2016 | 95 | 2016 |
| Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles K Kucharz, K Kristensen, KB Johnsen, MA Lund, M Lønstrup, T Moos, ... Nature communications 12 (1), 4121, 2021 | 93 | 2021 |
| On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems–A commentary KB Johnsen, JM Gudbergsson, M Duroux, T Moos, TL Andresen, ... Journal of controlled release 269, 10-14, 2018 | 88 | 2018 |
| Exosomes and autophagy: rekindling the vesicular waste hypothesis JM Gudbergsson, KB Johnsen Journal of cell communication and signaling 13 (4), 443-450, 2019 | 76 | 2019 |
| MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme—a systematic overview M Henriksen, KB Johnsen, HH Andersen, L Pilgaard, M Duroux Molecular neurobiology 50, 896-913, 2014 | 68 | 2014 |
| MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme M Henriksen, KB Johnsen, P Olesen, L Pilgaard, M Duroux Neuromolecular medicine 16, 565-577, 2014 | 51 | 2014 |
| Blood–brain barrier transport of transferrin receptor-targeted nanoparticles MS Thomsen, KB Johnsen, K Kucharz, M Lauritzen, T Moos Pharmaceutics 14 (10), 2237, 2022 | 43 | 2022 |
Torben MoosAalborg UniversityVerified email at hst.aau.dk
